(Q38395319)
Statements
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors (English)
M Candelaria
D Gallardo-Rincón
C Arce
L Cetina
J L Aguilar-Ponce
A González-Fierro
A Chávez-Blanco
E de la Cruz-Hernández
M F Camargo
C Trejo-Becerril
E Pérez-Cárdenas
L Taja-Chayeb
T Wegman-Ostrosky
A Revilla-Vazquez
A Dueñas-González
1 September 2007